TTC, Fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion

Journal of Neuroscience Methods

Volumn 179, Issue 1, 2009, Pages 1-8

  Liu, Fudong ^a,b   Schafer, Dorothy P ^a   McCullough, Louise D ^a,c  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b WANNAN MEDICAL COLLEGE   (China)

^c HARTFORD HOSPITAL   (United States)

Author keywords

Fluoro Jade B; Infarction; Ischemic stroke; Middle cerebral artery occlusion (MCAO); NeuN; Penumbra

Indexed keywords

FLUORESCENT DYE; FLUORO JADE B; NEURON SPECIFIC NUCLEAR PROTEIN; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN INJURY; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE MODEL; HISTOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STAINING; STROKE; TISSUE INJURY; VASCULAR LESION;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; BRAIN CHEMISTRY; BRAIN INFARCTION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; ORGANIC CHEMICALS; SEVERITY OF ILLNESS INDEX; STAINING AND LABELING; TETRAZOLIUM SALTS; TIME FACTORS;

EID: 61649086903     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2008.12.028     Document Type: Article

References (47)

1. Adkins D.L., Voorhies A.C., and Jones T.A. Behavioral and neuroplastic effects of focal endothelin-1 induced sensorimotor cortex lesions. Neuroscience 128 (2004) 473-486
2. Ajmo Jr. C.T., Vernon D.O., Collier L., Pennypacker K.R., and Cuevas J. Sigma receptor activation reduces infarct size at 24 h after permanent middle cerebral artery occlusion in rats. Curr Neurovasc Res 3 (2006) 89-98
3. Alexis N.E., Back T., Zhao W., Dietrich W.D., Watson B.D., and Ginsberg M.D. Neurobehavioral consequences of induced spreading depression following photothrombotic middle cerebral artery occlusion. Brain Res 706 (1996) 273-282
4. Aspey B.S., Cohen S., Patel Y., Terruli M., and Harrison M.J. Middle cerebral artery occlusion in the rat: consistent protocol for a model of stroke. Neuropathol Appl Neurobiol 24 (1998) 487-497
5. Baird A.E., Benfield A., Schlaug G., Siewert B., Lovblad K.O., Edelman R.R., and Warach S. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 41 (1997) 581-589
6. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., and Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17 (1986) 472-476
7. Bendel O., Alkass K., Bueters T., von Euler M., and von Euler G. Reproducible loss of CA1 neurons following carotid artery occlusion combined with halothane-induced hypotension. Brain Res 1033 (2005) 135-142
8. Benedek A., Moricz K., Juranyi Z., Gigler G., Levay G., Harsing Jr. L.G., Matyus P., Szenasi G., and Albert M. Use of TTC staining for the evaluation of tissue injury in the early phases of reperfusion after focal cerebral ischemia in rats. Brain Res 1116 (2006) 159-165
9. Butler T.L., Kassed C.A., Sanberg P.R., Willing A.E., and Pennypacker K.R. Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion. Brain Res 929 (2002) 252-260
10. Chen J., Jin K., Chen M., Pei W., Kawaguchi K., Greenberg D.A., and Simon R.P. Early detection of DNA strand breaks in the brain after transient focal ischemia: implications for the role of DNA damage in apoptosis and neuronal cell death. J Neurochem 69 (1997) 232-245
11. Chopp M., Zhang R.L., Zhang Z.G., and Jiang Q. The clot thickens-thrombolysis and combination therapies. Acta Neurochir Suppl 73 (1999) 67-71
12. Culmsee C., Zhu C., Landshamer S., Becattini B., Wagner E., Pellecchia M., Blomgren K., and Plesnila N. Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and Bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J Neurosci 25 (2005) 10262-10272
13. Davoli M.A., Fourtounis J., Tam J., Xanthoudakis S., Nicholson D., Robertson G.S., Ng G.Y., and Xu D. Immunohistochemical and biochemical assessment of caspase-3 activation and DNA fragmentation following transient focal ischemia in the rat. Neuroscience 115 (2002) 125-136
14. Dereski M.O., Chopp M., Knight R.A., Rodolosi L.C., and Garcia J.H. The heterogeneous temporal evolution of focal ischemic neuronal damage in the rat. Acta Neuropathol (Berl) 85 (1993) 327-333
15. DeVries A.C., Nelson R.J., Traystman R.J., and Hurn P.D. Cognitive and behavioral assessment in experimental stroke research: will it prove useful?. Neurosci Biobehav Rev 25 (2001) 325-342
16. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22 (1999) 391-397
17. Duckworth E.A., Butler T.L., De Mesquita D., Collier S.N., Collier L., and Pennypacker K.R. Temporary focal ischemia in the mouse: technical aspects and patterns of Fluoro-Jade evident neurodegeneration. Brain Res 1042 (2005) 29-36
18. Furlan M., Marchal G., Viader F., Derlon J.M., and Baron J.C. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol 40 (1996) 216-226
19. Garcia J.H., Yoshida Y., Chen H., Li Y., Zhang Z.G., Lian J., Chen S., and Chopp M. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am J Pathol 142 (1993) 623-635
20. Ginsberg M.D. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 55 (2008) 363-389
21. Grabowski M., Brundin P., and Johansson B.B. Paw-reaching, sensorimotor, and rotational behavior after brain infarction in rats. Stroke 24 (1993) 889-895
22. Hoehn M., Nicolay K., Franke C., and van der Sanden B. Application of magnetic resonance to animal models of cerebral ischemia. J Magn Reson Imaging 14 (2001) 491-509
23. Hossmann K.A. Disturbances of cerebral protein synthesis and ischemic cell death. Prog Brain Res 96 (1993) 161-177
24. Hoyte L.C., Papadakis M., Barber P.A., and Buchan A.M. Improved regional cerebral blood flow is important for the protection seen in a mouse model of late phase ischemic preconditioning. Brain Res 1121 (2006) 231-237
25. Igarashi T., Huang T.T., and Noble L.J. Regional vulnerability after traumatic brain injury: gender differences in mice that overexpress human copper, zinc superoxide dismutase. Exp Neurol 172 (2001) 332-341
26. Jorgensen H.S., Nakayama H., Raaschou H.O., Vive-Larsen J., Stoier M., and Olsen T.S. Outcome and time course of recovery in stroke: Part II. Time course of recovery. The Copenhagen Stroke Study. Arch Phys Med Rehabil 76 (1995) 406-412
27. Juttler E., Kohrmann M., and Schellinger P.D. Therapy for early reperfusion after stroke. Nat Clin Pract Cardiovasc Med 3 (2006) 656-663
28. Kudret T., Vemuganti R., Sailor K., and Dempsey R. Infarct volume quantification in mouse focal cerebral ischemia: a comparison of triphenyltetrazolium chloride and cresyl violet staining techniques. J Neurosci Methods 139 (2004) 203-207
29. Lafuente J.V., Mitre B., and Argandona E.G. Spatio-temporal distribution of apoptosis and the modulators thereof following a cortical microinfarct in rat brain. Neurosci Res 57 (2007) 354-361
30. Li X., Blizzard K.K., Zeng Z., DeVries A.C., Hurn P.D., and McCullough L.D. Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender. Exp Neurol 187 (2004) 94-104
31. Linnik M.D., Miller J.A., Sprinkle-Cavallo J., Mason P.J., Thompson F.Y., Montgomery L.R., and Schroeder K.K. Apoptotic DNA fragmentation in the rat cerebral cortex induced by permanent middle cerebral artery occlusion. Brain Res Mol Brain Res 32 (1995) 116-124
32. Lust W.D., Taylor C., Pundik S., Selman W.R., and Ratcheson R.A. Ischemic cell death: dynamics of delayed secondary energy failure during reperfusion following focal ischemia. Metab Brain Dis 17 (2002) 113-121
33. McCullough L.D., Blizzard K., Simpson E.R., Oz O.K., and Hurn P.D. Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection. J Neurosci 23 (2003) 8701-8705
34. McCullough L.D., McCullough L.D., Zeng Z., Blizzard K.K., Debchoudhury I., and Hurn P.D. Ischemic nitric oxide and poly (ADP-Ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. JCBFM 25 (2005) 502-512
35. Renolleau S., Fau S., Goyenvalle C., Joly L.M., Chauvier D., Jacotot E., Mariani J., and Charriaut-Marlangue C. Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: a role for gender. J Neurochem 100 (2007) 1062-1071
36. Roussel S.A., van Bruggen N., King M.D., and Gadian D.G. Identification of collaterally perfused areas following focal cerebral ischemia in the rat by comparison of gradient echo and diffusion-weighted MRI. J Cereb Blood Flow Metab 15 (1995) 578-586
37. Sampei K., Goto S., Alkayed N.J., Crain B.J., Korach K.S., Traystman R.J., Demas G.E., Nelson R.J., and Hurn P.D. Stroke in estrogen receptor-alpha-deficient mice. Stroke 31 (2000) 738-743 [discussion 744]
38. Schmued L.C., and Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874 (2000) 123-130
39. Schmued L.C., Albertson C., and Slikker Jr. W. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res 751 (1997) 37-46
40. Sugawara T., Lewen A., Noshita N., Gasche Y., and Chan P.H. Effects of global ischemia duration on neuronal, astroglial, oligodendroglial, and microglial reactions in the vulnerable hippocampal CA1 subregion in rats. J Neurotrauma 19 (2002) 85-98
41. Swanson R.A., Morton M.T., Tsao-Wu G., Savalos R.A., Davidson C., and Sharp F.R. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10 (1990) 290-293
42. Tamura A., Graham D.I., McCulloch J., and Teasdale G.M. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1 (1981) 53-60
43. Tureyen K., Vemuganti R., Sailor K.A., and Dempsey R.J. Infarct volume quantification in mouse focal cerebral ischemia: a comparison of triphenyltetrazolium chloride and cresyl violet staining techniques. J Neurosci Methods 139 (2004) 203-207
44. Unal-Cevik I., Kilinc M., Gursoy-Ozdemir Y., Gurer G., and Dalkara T. Loss of NeuN immunoreactivity after cerebral ischemia does not indicate neuronal cell loss: a cautionary note. Brain Res 1015 (2004) 169-174
45. van Lookeren Campagne M., Thomas G.R., Thibodeaux H., Palmer J.T., Williams S.P., Lowe D.G., and van Bruggen N. Secondary reduction in the apparent diffusion coefficient of water, increase in cerebral blood volume, and delayed neuronal death after middle cerebral artery occlusion and early reperfusion in the rat. J Cereb Blood Flow Metab 19 (1999) 1354-1364
46. Wahl F., Allix M., Plotkine M., and Boulu R.G. Neurological and behavioral outcomes of focal cerebral ischemia in rats. Stroke 23 (1992) 267-272
47. Wolf H.K., Buslei R., Schmidt-Kastner R., Schmidt-Kastner P.K., Pietsch T., Wiestler O.D., and Blumcke I. NeuN: a useful neuronal marker for diagnostic histopathology. J Histochem Cytochem 44 (1996) 1167-1171